Adaptive Partial Drug Approval: A Health Policy Proposal
AbstractCharles Manski of Northwestern argues that the drug approval process should be more continuous, so that patients can have access to beneficial drugs earlier and at the same time there are incentives for longer term studies than the current system produces, which could limit problems like those caused by Vioxx.
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.
Bibliographic InfoArticle provided by De Gruyter in its journal The Economists' Voice.
Volume (Year): 6 (2009)
Issue (Month): 4 (March)
Contact details of provider:
Web page: http://www.degruyter.com
You can help add them by filling out this form.
CitEc Project, subscribe to its RSS feed for this item.
- Prokop, Jacek & Regibeau, Pierre & Rockett, Katharine, 2010.
"Minimum quality standards and novelty requirements in a one-short development race,"
Economics - The Open-Access, Open-Assessment E-Journal,
Kiel Institute for the World Economy, vol. 4(15), pages 1-49.
- Prokop, Jacek & Regibeau, Pierre & Rockett, Katharine, 2009. "Minimum quality standards and novelty requirements in a one-shot development race," Economics Discussion Papers 2009-33, Kiel Institute for the World Economy.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Peter Golla).
If references are entirely missing, you can add them using this form.